X-ray of lung cancer being treated by interleukin

X-ray of lung cancer being treated by interleukin

M134/0150 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 2.9MB

Price image Pricing

Please login to use the price calculator


Caption: Immunotherapy. False-colour pulmonary X-ray showing a tumour (the dark red mass) in the lung on the left. The X-ray was made at the start of treatment with the genetically-engineered drug Interleukin-2 (IL-2). Compare with M134/151. IL-2 is used to artificially boost the immune response against certain human cancers. The implant chamber which delivers the drug is visible at top left. IL-2 is released naturally by certain key cells of the immune system (T- lymphocytes) that have been activated by foreign antigens - of cancer cells, for instance. It amplifies the proliferation of other types of T-cells - particularly the "killer" T-cells that attack cancer cells directly.

Release details: Model release not required. Property release not required.

Keywords: cancer imaging, cancer therapy, cancerous, chemotherap, chemotherapy, condition, disease, disorder, healthcare, il-2, image, immunotherapy, interleukin, interleukin-2, interleukin-2 (il-2), lung cancer, malignancy, malignant, medical, medicine, t-cell growth factor (tcgf), xray

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.